Repligen plans $100 million five-year convertibles to yield 1.625%-2.125%, up 22.5%-27.5%

By Rebecca Melvin

New York, May 18 – Repligen Corp. plans to price $100 million of five-year convertible senior notes before the market open on Thursday that were talked to yield 1.625% to 2.125% with an initial conversion premium of 22.5% to 27.5%, according to market sources.

The registered, off-the-shelf offering has a $15 million greenshoe and was being sold via bookrunner Jefferies & Co.

According to a company news release, the offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Waltham, Mass.-based Repligen is a bioprocessing company focused on the development, production and commercialization of products used in the production of monoclonal antibodies, recombinant proteins and vaccines.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.